Cellosaurus logo
expasy logo

Cellosaurus Colo829/R (CVCL_IW11)

[Text version]
Cell line name Colo829/R
Accession CVCL_IW11
Resource Identification Initiative To cite this cell line use: Colo829/R (RRID:CVCL_IW11)
Comments Population: Caucasian.
Selected for resistance to: ChEBI; CHEBI:90295; PLX-4720 (PLX4720).
Derived from site: In situ; Skin; UBERON=UBERON_0002097.
Sequence variations
  • Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
  • Mutation; HGNC; 1787; CDKN2A; Simple; p.Ala68Glyfs*51 (c.203_204delCG); Zygosity=Homozygous (from parent cell line).
  • Mutation; HGNC; 9588; PTEN; Simple; c.493_634del142; Zygosity=Homozygous (from parent cell line).
  • Mutation; HGNC; 11730; TERT; Simple; c.228_229CC>TT (-124/-125CC>TT); Zygosity=Unspecified; Note=In promoter (from parent cell line).
Disease Cutaneous melanoma (NCIt: C3510)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_1137 (COLO 829)
Sex of cell Male
Age at sampling 45Y
Category Cancer cell line
Publications

PubMed=26365896; DOI=10.1016/j.molonc.2015.08.003; PMCID=PMC4717845
Baenke F., Chaneton B., Smith M., van den Broek N.J.F., Hogan K., Tang H.-R., Viros A., Martin M., Galbraith L., Girotti M.R., Dhomen N., Gottlieb E., Marais R.
Resistance to BRAF inhibitors induces glutamine dependency in melanoma cells.
Mol. Oncol. 10:73-84(2016)

Cross-references
Cell line databases/resources cancercelllines; CVCL_IW11
Encyclopedic resources Wikidata; Q54814220
Entry history
Entry creation03-Mar-2017
Last entry update05-Oct-2023
Version number12